GF Venture Capital logo

GF Venture Capital

Asia, Guangdong, China, Guangzhou

Description

GF Venture Capital is a VC firm with activities that include equity investment, industrial investment, and securities investment.

Investor Profile

GF Venture Capital has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (67%)
  • Series Unknown (33%)

Country Focus

  • United States (67%)
  • China (33%)

Industry Focus

  • Manufacturing
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Computer
  • Field-programmable Gate Array (Fpga)
  • Hardware
  • Association
  • Non Profit
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GF Venture Capital frequently co-invest with?

China Fortune-Tech Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Co-Investments: 1
Huichuan Technology
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
YR
Asia, Hubei, China, Wuhan
Co-Investments: 1
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Finnova Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
GF Qianhe Investment
Asia, Beijing, China, Beijing
Co-Investments: 1
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Walden International
North America, California, United States, San Francisco
Co-Investments: 1
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1

What are some of recent deals done by GF Venture Capital?

Hercules Microsystems

Beijing, Beijing, China

Hercules Microsystems is a developer of programmable computing chips. They also provide testing and maintenance circuits and other services.

Artificial Intelligence (AI)ComputerField-Programmable Gate Array (FPGA)HardwareManufacturing
Series BDec 3, 2021
MabPlex International

Fremont, California, United States

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

AssociationBiotechnologyManufacturingNon Profit
Series BJun 8, 2020
Amount Raised: $70,708,356
Rani Therapeutics

San Jose, California, United States

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownFeb 27, 2016